The impact of disease-drug interactions on drug development and clinical practice

被引:5
|
作者
Cai, Hualin [1 ,2 ]
Chen, Xia [3 ,4 ]
机构
[1] Cent South Univ, Dept Pharm, Xiangya Hosp 2, Changsha, Peoples R China
[2] Cent South Univ, Inst Clin Pharm, Changsha, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Phase Unit 1, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
关键词
PHARMACOKINETICS;
D O I
10.1111/bcp.14469
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:712 / 714
页数:3
相关论文
共 50 条
  • [21] Pharmacogenomics in clinical practice and drug development
    Harper, Andrew R.
    Topol, Eric J.
    NATURE BIOTECHNOLOGY, 2012, 30 (11) : 1117 - 1124
  • [22] PERSONALISED MEDICINE AND ITS IMPACT ON DRUG DEVELOPMENT, AUTHORIZATION AND CLINICAL PRACTICE
    del Barrio, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 25 - 25
  • [23] DEVELOPMENT OF A PBPK MODEL OF CYP3A AND CYP2C19 DOWNREGULATION BY INTERLEUKIN-6 AND ESOMEPRAZOLE: PREDICTION OF DISEASE-DRUG AND DRUG-DRUG INTERACTIONS
    Lenoir, Camille
    Niederer, Amine
    Rollason, Victoria
    Desmeules, Jules Alexandre
    Daali, Youssef
    Samer, Caroline Flora
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 2 - 2
  • [24] Automated acquisition of disease-drug knowledge from biomedical and clinical documents: An initial study
    Chen, Elizabeth S.
    Hripcsak, George
    Xu, Hua
    Markatou, Marianthi
    Friedman, Carol
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2008, 15 (01) : 87 - 98
  • [25] Clinical impact of drug-drug interactions with systemic azole antifungals
    Bates, DW
    Yu, DT
    DRUGS OF TODAY, 2003, 39 (10): : 801 - 813
  • [26] Drug-drug interactions in HCV therapy: Still relevant for clinical practice?
    Schulte, Benjamin
    Wubbolding, Maximilian
    Port, Kerstin
    Manns, Michael P.
    Back, David
    Marra, Fiona
    Cornberg, Markus
    Maasoumy, Benjamin
    zu Siederdissen, Christoph Hoener
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E240 - E240
  • [27] Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Corsini, Alberto
    Ferri, Nicola
    Proietti, Marco
    Boriani, Giuseppe
    DRUGS, 2020, 80 (11) : 1065 - 1083
  • [28] Drug-Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?
    Bourdin, Venceslas
    Bigot, William
    Vanjak, Anthony
    Burlacu, Ruxandra
    Lopes, Amanda
    Champion, Karine
    Depond, Audrey
    Amador-Borrero, Blanca
    Sene, Damien
    Comarmond, Chloe
    Mouly, Stephane
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [29] Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Alberto Corsini
    Nicola Ferri
    Marco Proietti
    Giuseppe Boriani
    Drugs, 2020, 80 : 1065 - 1083
  • [30] A new computational drug repurposing method using established disease-drug pair knowledge
    Saberian, Nafiseh
    Peyvandipour, Azam
    Donato, Michele
    Ansari, Sahar
    Draghici, Sorin
    BIOINFORMATICS, 2019, 35 (19) : 3672 - 3678